On Sept. 22, 2021, the Breakthrough Prize Foundation and its founding sponsors announced the 2022 winners of the…
On Sept. 22, 2021, Dynavax Technologies announced that Clover Biopharmaceuticals reported positive data for their protein-based COVID-19 vaccine…
On Sept. 22, 2021, Gilead Sciences announced positive results from a Phase 3 randomized, double-blind, placebo-controlled trial to…
On Sept. 22, 2021, Pfizer and BioNTech announced plans to expand their agreement with the U.S. government by…
On Sept. 22, 2021, Inovio Pharmaceuticals announced that it had received authorization from COFEPRIS, the national health regulatory…
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
On Sept. 20, 2021, Eiger BioPharmaceuticals announced announced that Peginterferon Lambda (Lambda) will be added to the ongoing,…
On Sept. 20, 2021, Pfizer and BioNTech announced results from a Phase 2/3 trial showing a favorable safety…
On Sept. 20, 2021, the University of Oxford and Oracle’s Global Pathogen Analysis System announced that it was…
On Sept. 17, 2021, the lions and tigers at the Smithsonian’s National Zoo were reported testing presumptive positive…
On Sept. 17, 2021, Zoo Atlanta reported that of the 20 gorillas at the Zoo, 18 showed clinical…
On Sept. 17, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Sept. 17, 2021, the Centers for Disease Control and Prevention (CDC) announced a $2.1 billion investment to…
On Sept. 17, 2021, Oxfordï¾’s Leverhulme Centre for Demographic Science reported the COVID-19 pandemic triggered life expectancy losses…
On Sept. 16, 2021, the WHO reported that the continent faced almost 500 million doses short of the…
On Sept. 16, 2021, Moderna announced Health Canada has approved the New Drug Submission (NDS-CV) for SPIKEVAXï¾™ (elasomeran…
On Sept. 16, 2021, Novavax announced its participation in a newly expanded Phase 2 clinical trial called Comparing…
On Sept. 16, 2021, Celsion and Hainan Poly Pharm announced an amendment to their existing contract manufacturing agreement…
On Sept. 15, 2021, the National Institutes of Health (NIH) awarded nearly $470 million to build a national…
On Sept. 15, 2021, Guinea declared the end of the Marburg virus disease outbreak having recorded no new…
On Sept. 15, 2021, Oragenics announced the initiation of a study to evaluate the immunogenicity and viral load…
On Sept. 15, 2021, Moderna announced new analysis suggesting that the Moderna COVID-19 vaccine was highly effective against…
On Sept. 15, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Sept. 15, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
On Sept. 14, 2021, the WHO Director General Dr Tedros Adhanom Ghebreyesus and a group of global health…
On Sept. 14, 2021, the NIH announced that an international project called the COVID Human Genetic Effort has…
On Sept. 14, 2021, Emergent BioSolutions announced a five-year contract development and manufacturing (CDMO) services agreement spanning Emergentï¾’s…
On Sept. 14, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…
On Sept. 14, 2021, Regeneron announced an agreement with the U.S. Department of Health and Human Services and…
On Sept. 14, 2021, City of Hope announced that it had begun enrolling patients in a Phase 2…